NYSE
11 hours, 16 minutes ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $575,000 through a pre-arranged Rule 10b5-1 trading plan.

NYSE
1 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 26, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
2 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $12.55 per share on June 25, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

NYSE
3 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock at an average price of $12.4876 per share, executed under a Rule 10b5-1 trading plan.

NYSE
4 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 23, 2025, through a pre-arranged 10b5-1 trading plan.

NYSE
7 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Reports Sale of 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 20, 2025, executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE
9 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 18, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
10 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 17, 2025, executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE
11 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 90,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 90,000 Class A Common Stock shares through a Rule 10b5-1 trading plan.

NYSE
15 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells $1.16 Million in Company Stock Under Pre-Arranged Plan
UiPath, Inc. CEO and Chairman Daniel Dines executed the sale of 90,000 shares of Class A Common Stock over two days in June 2025, totaling approximately $1.16 million, as part of a pre-established Rule 10b5-1 trading plan.

NYSE
17 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $593,491 under a Rule 10b5-1 trading plan.
Worse than expected
 

NYSE
18 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.08 per share, executed under a Rule 10b5-1 trading plan.

NYSE
21 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $589,779, executed under a Rule 10b5-1 trading plan.

NYSE
22 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines has sold 45,000 shares of Class A Common Stock for approximately $592,492 under a Rule 10b5-1 trading plan.
Worse than expected
 

NYSE
23 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 4, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
24 days, 12 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports Q1 2025 Revenue Growth Amidst Strategic Shift to AI and Cloud, Narrows Net Loss
UiPath, a leader in enterprise automation software, announced a 6% increase in total revenue to $356.6 million and a 12% rise in Annualized Renewal Run-Rate (ARR) to $1.69 billion for the first quarter ended April 30, 2025, while significantly narrowing its net loss.

NYSE
24 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 3, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
25 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.31 per share, executed under a Rule 10b5-1 trading plan.

NYSE
29 days, 12 hours ago 
PATH
Uipath, INC
8-K: UiPath Exceeds Q1 Fiscal 2026 Expectations with Strong ARR Growth and Agentic Automation Platform Launch
UiPath, a global leader in agentic automation, reported first quarter fiscal 2026 financial results that surpassed guidance, driven by robust ARR growth and the successful launch of its next-generation agentic automation platform.
Better than expected
 

NYSE
43 days, 11 hours ago 
PATH
Uipath, INC
SCHEDULE 13G: Bank of America Discloses 5.6% Stake in UiPath, Inc. Class A Common Stock
Bank of America Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.6% of UiPath, Inc.'s Class A common stock as of March 31, 2025.

NYSE
44 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $13.176 per share on May 14, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
45 days, 7 hours ago 
PATH
Uipath, INC
DEFA14A: UiPath, Inc. Files Definitive Proxy Statement with SEC
UiPath, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) related to its upcoming shareholder meeting.

NYSE
45 days, 11 hours ago 
PATH
Uipath, INC
DEF: UiPath Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
UiPath will hold its Annual Meeting of Stockholders virtually on June 26, 2025, to vote on director elections, executive compensation, and the ratification of KPMG LLP as the independent auditor.
Worse than expected
 

NYSE
45 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $13.1224, according to a Form 4 filing.

NYSE
46 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $12.8332, pursuant to a pre-arranged 10b5-1 trading plan.

NYSE
49 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.5076, according to a Form 4 filing.

NYSE
50 days, 11 hours ago 
PATH
Uipath, INC
8-K: UiPath Director Laela Sturdy to Resign from Board at 2025 Annual Meeting
Laela Sturdy will resign from UiPath's Board of Directors prior to the 2025 Annual Meeting of Stockholders.

NYSE
50 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.1619, according to a Form 4 filing.

NYSE
51 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.0284, according to a Form 4 filing with the SEC.

NYSE
52 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 14,900 shares of Class A Common Stock at an average price of $12.0077 per share on May 6, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
53 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 24,979 shares of Class A Common Stock at an average price of $12.0279 on May 5, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
56 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $12.0152, according to a Form 4 filing with the SEC.

NYSE
56 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Sells Shares Under 10b5-1 Plan
Ashim Gupta, COO & CFO of UiPath, sold 99,300 shares of Class A Common Stock on May 1, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
57 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO, Daniel Dines, executed a sale of 45,000 shares of Class A Common Stock at an average price of $12.0058, as part of a pre-arranged trading plan.

NYSE
81 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Sells 12,500 Shares Under 10b5-1 Plan
UiPath's Chief Accounting Officer, Hitesh Ramani, sold 12,500 shares of Class A Common Stock at an average price of $10.1858, as part of a pre-arranged trading plan.

NYSE
85 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Brad Brubaker Reports Stock Disposal for Tax Obligations
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports disposing of shares to cover tax obligations arising from vested restricted stock units.

NYSE
85 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Tax-Related Stock Disposal
Ashim Gupta, COO & CFO of UiPath, reports the disposal of shares to cover tax obligations upon the vesting of restricted stock units.

NYSE
85 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Disposes of Shares to Cover Tax Obligations
Hitesh Ramani, Chief Accounting Officer of UiPath, disposed of 22,595 shares of Class A Common Stock on April 1, 2025, to cover tax obligations arising from the vesting of restricted stock units.

NYSE
95 days, 11 hours ago 
PATH
Uipath, INC
10-K: UiPath's FY25 Revenue Climbs 9% Amid Strategic Shifts and AI Investments
UiPath reports a 9% increase in revenue for fiscal year 2025, driven by subscription growth and strategic investments in AI, while navigating leadership changes and macroeconomic headwinds.
Worse than expected
 

NYSE
101 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Award
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the acquisition of 93,065 shares of Class A Common Stock through Restricted Stock Units (RSUs).

NYSE
101 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Acquisition of 288,321 Shares of Class A Common Stock
Ashim Gupta, COO & CFO of UiPath, reports acquiring 288,321 shares of Class A Common Stock through Restricted Stock Units (RSUs) on March 14, 2025.

NYSE
101 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath GC & Chief Legal Officer Brad Brubaker Reports Acquisition of Restricted Stock Units
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports the acquisition of 145,985 Restricted Stock Units (RSUs) on March 14, 2025.

NYSE
102 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Converts 5 Million Class B Shares to Class A Under 10b5-1 Trading Plan
UiPath's CEO, Daniel Dines, converted 5 million Class B shares to Class A shares on March 13, 2025, under a pre-arranged trading plan.

NYSE
107 days, 12 hours ago 
PATH
Uipath, INC
8-K: UiPath Reports Q4 and Full Year Fiscal 2025 Financial Results; Announces Acquisition of Peak AI
UiPath announces its Q4 and full year fiscal 2025 results, highlighting revenue growth, ARR increase, and the acquisition of Peak AI to enhance its AI capabilities.
Delay expected
 
Worse than expected
 

NYSE
120 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Sells 12,500 Shares Under 10b5-1 Plan
UiPath's Chief Accounting Officer, Hitesh Ramani, sold 12,500 shares of Class A Common Stock at an average price of $12.6759, according to a Form 4 filing.

NYSE
140 days, 11 hours ago 
PATH
Uipath, INC
SCHEDULE 13G/A: Vanguard Group Discloses 10.22% Passive Stake in UiPath Inc.
The Vanguard Group has reported a 10.22% beneficial ownership stake in UiPath Inc., holding 47,754,958 shares as of January 31, 2025, as a passive investor.

NYSE
168 days, 1 hours ago 
PATH
Uipath, INC
SCHEDULE 13G/A: ARK Investment Management Updates UiPath Stake, Reports 4.48% Beneficial Ownership
ARK Investment Management LLC has filed an Amendment No. 4 to its Schedule 13G, disclosing a 4.48% beneficial ownership stake in UiPath, Inc.'s Class A common stock as of September 30, 2024.

NYSE
172 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Transactions
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the disposal and acquisition of Class A Common Stock on January 2nd and 3rd, 2025.

NYSE
172 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Stock Transactions
Ashim Gupta, COO & CFO of UiPath, reports the disposition and acquisition of Class A Common Stock on January 2nd and 3rd, 2025.

NYSE
172 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Brad Brubaker Reports Stock Transaction
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports the disposal of 41,966 shares to cover tax obligations related to vested restricted stock units.

NYSE
198 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Sells 55,000 Shares Under 10b5-1 Plan
UiPath's COO & CFO, Ashim Gupta, sold 55,000 shares of Class A Common Stock at an average price of $15.6127 per share under a pre-arranged 10b5-1 trading plan.

NYSE
203 days, 8 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports 9% Revenue Growth in Q3 2025, Driven by Subscription Services
UiPath's Q3 2025 results show a 9% year-over-year revenue increase, fueled by a strong performance in subscription services, despite a decrease in license revenue.
Worse than expected
 
Capital raise
 

NYSE
204 days, 11 hours ago 
PATH
Uipath, INC
8-K: UiPath Reports Strong Q3 Fiscal 2025 Results, Driven by AI and Automation Growth
UiPath's Q3 fiscal 2025 results show a 9% year-over-year revenue increase to $355 million and a 17% increase in ARR to $1.607 billion, highlighting the company's growth in the AI-powered automation market.
Better than expected
 

NYSE
263 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO Ashim Gupta Reports Sale of Shares Under 10b5-1 Plan
UiPath's COO & CFO, Ashim Gupta, reported the sale of 47,227 shares of Class A Common Stock on October 3, 2024, under a pre-arranged 10b5-1 trading plan.

NYSE
263 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Sells 25,000 Shares Under 10b5-1 Plan
UiPath's Chief Accounting Officer, Hitesh Ramani, sold 25,000 shares of Class A Common Stock at an average price of $11.9977, executed under a pre-arranged 10b5-1 trading plan.

NYSE
268 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Changes in Beneficial Ownership
Ashim Gupta, COO & CFO of UiPath, reports the acquisition and disposal of Class A Common Stock due to tax obligations and vesting of restricted stock units.

NYSE
268 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Transactions
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

NYSE
268 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath GC & Chief Legal Officer Brad Brubaker Reports Stock Transactions
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

NYSE
283 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO Ashim Gupta Sells Shares Under 10b5-1 Plan
UiPath's COO & CFO, Ashim Gupta, executed sales of Class A Common Stock on September 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

NYSE
287 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Chief Accounting Officer Hitesh Ramani Sells $25,000 in Class A Common Stock
Hitesh Ramani, Chief Accounting Officer of UiPath, sold 25,000 shares of Class A Common Stock on September 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

NYSE
294 days, 11 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports 10% Revenue Growth in Q2 2025, Driven by Subscription Services
UiPath's Q2 2025 results show a 10% year-over-year revenue increase, fueled by strong growth in subscription services, despite a decrease in license revenue.
Worse than expected
 

NYSE
294 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Somasegar Sivaramakichenane Reports Acquisition of 47,694 Class A Common Stock Shares
Director Somasegar Sivaramakichenane reports acquiring 47,694 shares of UiPath's Class A Common Stock through a grant of Restricted Stock Units (RSUs).

NYSE
295 days, 12 hours ago 
PATH
Uipath, INC
8-K: UiPath Announces Q2 Fiscal 2025 Results, Board and Leadership Changes, and $500 Million Stock Repurchase Expansion
UiPath reported a 10% year-over-year revenue increase to $316 million and a 19% increase in ARR to $1.551 billion for Q2 fiscal 2025, alongside leadership changes and a stock repurchase program expansion.
Better than expected
 

NYSE
353 days, 21 hours ago 
PATH
Uipath, INC
8-K: UiPath Announces Restructuring Plan Involving 10% Workforce Reduction
UiPath is implementing a restructuring plan that includes a 10% reduction in its global workforce to improve operational efficiency and focus on AI.

NYSE
360 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Disposes of Shares to Cover Tax Obligations
Hitesh Ramani, Chief Accounting Officer of UiPath, disposed of 21,289 shares of Class A Common Stock on July 1, 2024, to cover tax obligations arising from the vesting of restricted stock units.

NYSE
360 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CFO Ashim Gupta Reports Stock Transactions
UiPath's Chief Financial Officer, Ashim Gupta, reported the disposal of shares to cover tax obligations and also reports shares held by trust.

NYSE
360 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Brad Brubaker Disposes of Shares to Cover Tax Obligations
Brad Brubaker, GC & Chief Legal Officer of UiPath, disposed of 22,404 shares to cover tax obligations arising from the vesting of restricted stock units.

NYSE
366 days, 12 hours ago 
PATH
Uipath, INC
8-K: UiPath Stockholders Approve Director Elections and Executive Compensation at Annual Meeting
UiPath's annual meeting saw shareholders approve the election of eight directors, executive compensation, and the ratification of KPMG as the company's auditor.

NYSE
368 days, 9 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Richard Wong Reports Share Acquisition and Corrects Previous Filing Error
Director Richard Wong reports acquisition of shares via Restricted Stock Units (RSUs) and corrects an administrative error in a previous Form 4 filing.

NYSE
368 days, 9 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Philippe Botteri Receives Stock Grant
Philippe Botteri, a director at UiPath, received a grant of Class A Common Stock and Restricted Stock Units (RSUs) on June 20, 2024.

NYSE
368 days, 9 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director June Yang Reports Acquisition of Shares
Director June Yang reports acquisition of UiPath Class A Common Stock and Restricted Stock Units (RSUs) on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Karenann Terrell Receives Stock Grant
Director Karenann Terrell received a grant of 17,021 Restricted Stock Units (RSUs) from UiPath, Inc. on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Daniel D. Springer Reports Acquisition of Restricted Stock Units
Director Daniel D. Springer reports the acquisition of 17,021 Restricted Stock Units (RSUs) of UiPath, Inc. on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Laela Sturdy Receives Stock Grant
Laela Sturdy, a director at UiPath, acquired 17,021 shares of Class A Common Stock through a grant on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Michael Lawrence Gordon Reports Acquisition of Restricted Stock Units
Director Michael Lawrence Gordon reports the acquisition of 17,021 Restricted Stock Units (RSUs) in UiPath, Inc.

NYSE
378 days, 12 hours ago 
PATH
Uipath, INC
4/A: UiPath Executive Robert Enslin Corrects Shareholding Disclosure After Tax Obligation
Robert Enslin, former CEO and Director of UiPath, files an amended Form 4 to correct the number of shares beneficially owned following a transaction related to tax obligations from vested restricted stock units.

NYSE
389 days, 11 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports 16% Revenue Growth and Strong Cash Flow in Q1 2025
UiPath's first quarter of fiscal year 2025 shows a 16% year-over-year revenue increase and strong cash flow from operations.

NYSE
394 days, 12 hours ago 
PATH
Uipath, INC
DEFA14A: UiPath CEO Robert Enslin Resigns, Founder Daniel Dines Returns to Helm
Robert Enslin resigned as UiPath's CEO, with founder Daniel Dines stepping back into the role, effective June 1, 2024.

NYSE
394 days, 12 hours ago 
PATH
Uipath, INC
8-K: UiPath CEO Robert Enslin Resigns, Founder Daniel Dines Returns to Helm
UiPath's CEO, Robert Enslin, has resigned, and founder Daniel Dines will take over the role effective June 1, 2024.
Worse than expected
 

NYSE
394 days, 12 hours ago 
PATH
Uipath, INC
8-K: UiPath Reports Strong Q1 Fiscal 2025 Results Amidst Leadership Transition
UiPath announced its Q1 fiscal 2025 results, showcasing a 16% year-over-year revenue increase and a 21% increase in ARR, while also announcing a CEO transition.
Worse than expected
 

NYSE
406 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Robert Enslin Reports Stock Transaction
UiPath's CEO, Robert Enslin, reports the disposition of 40,005 shares to cover tax obligations related to vested restricted stock units.

NYSE
414 days, 10 hours ago 
PATH
Uipath, INC
8-K: UiPath Invests $35.2 Million in AI Startup H.AI
UiPath has agreed to invest approximately $35.2 million in H.AI, a France-based artificial intelligence company, through a combination of cash and convertible bonds.

NYSE
414 days, 11 hours ago 
PATH
Uipath, INC
DEFA14A: UiPath, Inc. Files Definitive Proxy Statement
UiPath, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.

NYSE
414 days, 11 hours ago 
PATH
Uipath, INC
DEF 14A: UiPath Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
UiPath's annual stockholders meeting will be held virtually on June 20, 2024, to vote on director elections, executive compensation, and the ratification of KPMG LLP as the independent auditor.
Worse than expected
 

NYSE
415 days, 9 hours ago 
PATH
Uipath, INC
Form 4: UiPath CFO Ashim Gupta Sells Shares Under 10b5-1 Plan
UiPath's Chief Financial Officer, Ashim Gupta, executed sales of Class A Common Stock on May 6, 2024, under a pre-arranged 10b5-1 trading plan.

NYSE
444 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CFO Ashim Gupta Sells Shares Under 10b5-1 Plan, Acquires Restricted Stock Units
UiPath's Chief Financial Officer, Ashim Gupta, executed sales of Class A Common Stock under a pre-arranged 10b5-1 trading plan and acquired restricted stock units.

NYSE
444 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Robert Enslin Reports Acquisition of Restricted Stock Units
UiPath CEO Robert Enslin reports the acquisition of 652,173 Restricted Stock Units (RSUs) on April 5, 2024, according to a Form 4 filing with the SEC.

NYSE
444 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Award
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the acquisition of 52,173 shares of Class A Common Stock through Restricted Stock Units (RSUs).

NYSE
444 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath GC & Chief Legal Officer Brad Brubaker Reports Stock Award
Brad Brubaker, General Counsel & Chief Legal Officer of UiPath, Inc., reports the acquisition of 182,608 shares of Class A Common Stock through Restricted Stock Units (RSUs) on April 5, 2024.

NYSE
450 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Tax-Related Stock Disposal
Hitesh Ramani, Chief Accounting Officer of UiPath, disposed of 19,068 shares of Class A Common Stock on April 1, 2024, to cover tax obligations related to vesting restricted stock units.

PATH 
Uipath, INC 
NYSE

DEF 14A: UiPath Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals

Sentiment:
 Proxy Statement
 9 May 2024 5:00 PM

UiPath's annual stockholders meeting will be held virtually on June 20, 2024, to vote on director elections, executive compensation, and the ratification of KPMG LLP as the independent auditor.

Worse than expected
  The company did not achieve 100% of its iARR target for fiscal year 2024, achieving 82% of the target. 

Summary
  • UiPath will hold its Annual Meeting of Stockholders virtually on June 20, 2024, at 11:00 a.m. Eastern Time.
  • Stockholders of record as of April 26, 2024, are eligible to vote.
  • The meeting will address the election of nine directors, an advisory vote on executive compensation, and the ratification of KPMG LLP as the independent registered public accounting firm for the fiscal year ending January 31, 2025.
  • The board recommends voting 'FOR' all director nominees, the say-on-pay proposal, and the ratification of KPMG.
  • In fiscal year 2024, UiPath's revenue increased 24% year-over-year to $1,308.1 million, and ARR increased 22% year-over-year to $1,463.7 million.
  • The company's gross margin was 85% for fiscal year 2024, compared to 83% in fiscal year 2023.
  • As of January 31, 2024, UiPath had $1,880.3 million in cash, cash equivalents, restricted cash, and marketable securities.
Sentiment

Score: 7

Explanation: The document presents a mix of positive financial results (revenue and ARR growth, improved gross margin) and some challenges (not achieving iARR target). The transition in leadership roles is also a significant development. Overall, the sentiment is cautiously optimistic.

Positives
  • The company experienced significant revenue and ARR growth in fiscal year 2024.
  • Gross margin improved, indicating increased efficiency.
  • UiPath maintains a strong cash position.
  • The board is committed to good corporate governance practices, including independent directors and a lead independent director.
  • Stockholders have multiple avenues to vote, including online, by phone, or by mail.
Negatives
  • The company reported a net loss of $89.883 million in fiscal year 2024.
  • The company did not achieve 100% of its iARR target for fiscal year 2024, achieving 82% of the target.
Risks
  • The document mentions the importance of monitoring new threats and risks, including developments in AI technologies and the global macroeconomic environment.
  • The company's performance is subject to legal and regulatory requirements, including data privacy and information security risks.
  • The company's compensation policies and programs could potentially encourage excessive risk-taking, although the compensation committee believes this is unlikely.
Future Outlook

The company is focused on evolving AI-powered automation and inspiring customers to see automation more holistically.

Management Comments
  • Daniel Dines moved into a new role of Chief Innovation Officer as of February 1, 2024, to enable him to focus more on our product and vision.
Industry Context

UiPath is positioned as a leader in the automation space, leveraging AI and machine learning to drive digital transformation for its customers.

Comparison to Industry Standards
  • The document compares UiPath's executive compensation to a peer group of public companies in application software, internet services and infrastructure, systems software, and healthcare technology.
  • The peer group includes companies such as Asana, Avalara, Cloudflare, Confluent, Coupa Software, Crowdstrike Holdings, Datadog, DocuSign, Dynatrace, Elastic N.V., MongoDB, Okta, Palantir Technologies, Paylocity Holding, Procore Technologies, Qualtrics International, RingCentral, Samsara, Snowflake, The Trade Desk, Twilio, Unity Software, and Zscaler.
  • The compensation committee reviews market data from these peer companies to inform its decisions regarding executive compensation levels.
Stakeholder Impact
  • Stockholders are provided with information to make informed decisions regarding director elections, executive compensation, and auditor ratification.
  • Employees are impacted by the company's compensation policies and benefit plans.
  • The company's performance and strategic direction impact customers and other stakeholders.
Next Steps
  • Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
  • The company will announce the results of the voting at the Annual Meeting and in a subsequent Form 8-K filing.
Related Party Transactions
  • Aharon Dines, the brother of Daniel Dines, is employed by UiPath SRL and received 602,783 RON in compensation, additional cash compensation of 158,000 RON, and stock options with an aggregate grant date fair value of $32,868 for the fiscal year ended January 31, 2024.
  • UiPath invested $35.2 million in the H company, a France-based early-stage foundation model and agentic artificial intelligence company, alongside Accel.
  • Mr. Botteri and Mr. Wong, each a member of our board, are partners at Accel and Mr. Botteri will serve on the H company board of directors.
Key Dates
  • February 1, 2023: Start date for related party transactions disclosure period.
  • March 7, 2023: Carl Eschenbach stepped down from the board of directors.
  • April 7, 2023: Karenann Terrell was appointed to the board of directors.
  • April 13, 2023: Jennifer Tejada resigned from the board of directors.
  • August 2023: The Incentive Compensation Recoupment Policy (the Clawback Policy) was adopted by our board of directors.
  • October 2, 2023: Effective date of the Clawback Policy.
  • November 1, 2023: Date used to identify the global median employee for CEO pay ratio calculation.
  • January 10, 2024: Robert Enslin and June Yang were appointed to the board of directors.
  • February 1, 2024: Robert Enslin became the sole Chief Executive Officer and Daniel Dines became Chief Innovation Officer; June Yang's board appointment became effective; Stock Ownership Policy effective.
  • January 31, 2024: End of fiscal year 2024.
  • April 26, 2024: Record date for the Annual Meeting.
  • May 9, 2024: Expected date of mailing the Notice of Internet Availability of Proxy Materials.
  • June 20, 2024: Date of the Annual Meeting of Stockholders.
  • January 8, 2025: Deadline for stockholder proposals to be included in next year's proxy materials.
  • February 20, 2025: Earliest date for submitting a proposal (including a director nomination) at the 2025 Annual Meeting.
  • March 22, 2025: Latest date for submitting a proposal (including a director nomination) at the 2025 Annual Meeting.
Keywords
Annual Meeting, Proxy Statement, Stockholders, Directors, Executive Compensation, KPMG, ARR, Revenue, Governance, UiPath

PATH 
Uipath, INC 
NYSE
Sector: TBD
 
Filings with Classifications
Worse than expected
10 June 2025 5:28 PM

Insider Trading Report
  • The sale of shares by a high-ranking executive and significant shareholder, even under a Rule 10b5-1 plan, is generally viewed as a negative signal by the market, as it reduces the insider's direct stake in the company.
Worse than expected
5 June 2025 4:13 PM

SEC Form 4
  • The sale of shares by a key executive like the CEO, even if pre-planned, can be interpreted as a lack of confidence or a signal that the stock may not appreciate significantly in the near term, which is generally viewed as a negative indicator for investors.
Better than expected
29 May 2025 4:16 PM

Quarterly Report
  • First quarter results exceeded the company's guidance on both the top line (revenue) and bottom line (non-GAAP operating income).
  • Achieved significant year-over-year expansion in non-GAAP operating margin.
Worse than expected
13 May 2025 4:57 PM

Proxy Statement
  • The company's gross margin decreased from 85% in fiscal year 2024 to 83% in fiscal year 2025.
  • The company's cash and cash equivalents, restricted cash, and marketable securities decreased from $1,880.3 million as of January 31, 2024 to $1,724.1 million as of January 31, 2025.
Worse than expected
24 March 2025 5:27 PM

Annual Report on Form 10-K
  • Revenue growth slowed to 9% compared to prior periods.
  • Gross margin decreased from 85% to 83%.
Delay expected
12 March 2025 4:23 PM

Earnings Release
  • The restructuring costs are now expected to be incurred by the end of the second quarter of fiscal year 2026, extending the original timeline.
Worse than expected
12 March 2025 4:23 PM

Earnings Release
  • The financial outlook for fiscal year 2026 reflects increasing global macro economic uncertainty, particularly in the U.S. public sector, resulting in lower revenue and ARR projections than previously anticipated.
Worse than expected
6 December 2024 7:13 PM

Quarterly Report
  • The company's gross margin decreased to 82% for the quarter, down from 85% in the same quarter of the previous year.
  • The company reported a net loss of $10.7 million for the quarter and $125.5 million year-to-date.
  • Interest income decreased by 31% for the quarter due to lower cash balances and decreased interest rates.
Capital raise
6 December 2024 7:13 PM

Quarterly Report
  • The company may be required to seek additional equity or debt financing in the future.
Better than expected
5 December 2024 4:14 PM

Quarterly Report
  • The company's third quarter results exceeded expectations, reflecting improved execution and customer response to their new vision.
Worse than expected
6 September 2024 5:13 PM

Quarterly Report
  • The company's gross margin decreased from 83% to 80% due to increased costs in subscription services.
  • The operating loss increased from $77.6 million to $103.3 million year-over-year.
  • License revenue decreased by 6% year-over-year.
Better than expected
5 September 2024 4:17 PM

Quarterly Report
  • The company's ARR growth of 19% year-over-year exceeded expectations.
  • The company's non-GAAP adjusted free cash flow of $49 million was better than anticipated.
  • The company raised its full year profitability guidance.
Worse than expected
29 May 2024 4:25 PM

Executive Change Announcement
  • The unexpected resignation of the CEO is generally viewed negatively by the market.
Worse than expected
29 May 2024 4:18 PM

Quarterly Report
  • The company has lowered its full year revenue and operating margin guidance due to increased deal scrutiny and lengthening sales cycles.
Worse than expected
9 May 2024 5:00 PM

Proxy Statement
  • The company did not achieve 100% of its iARR target for fiscal year 2024, achieving 82% of the target.
Worse than expected
27 March 2024 5:26 PM

Annual Results
  • Despite revenue growth, the company reported a net loss for the year, indicating that profitability is still a challenge.
Better than expected
13 March 2024 4:17 PM

Quarterly Report
  • The company achieved its first quarter of GAAP profitability as a public company, which is better than expected.
  • The company's revenue and ARR growth exceeded expectations.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.